Open an account

Invesco Biotechnology & Genome ETF

PBE · ETF

$98.72−$0.6637 (−0.67%)TodayMarket closed ·
Prev close $99.38

About PBE

PBE was created on 2005-06-23 by Invesco. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 418.54m in AUM and 32 holdings. PBE tracks a tiered equal-weighted index of companies principally engaged in biotechnology and genetic engineering.

Issuer
Invesco
Tracks
Dynamic Biotech & Genome Intellidex Index (AMEX)
Expense ratio
0.59%
Assets under management
$431.71M
Inception
Jun 23, 2005
Asset class
Equity
Website
invesco.com

PBE key statistics

Market cap
0
Price-earnings ratio
0.00
Average volume
13.39K
Volume
7.73K
Open price
$98.74
High today
$98.72
Low today
$97.57
52 Week high
$99.99
52 Week low
$72.27

Invesco Biotechnology & Genome ETF (PBE) at a glance

Invesco Biotechnology & Genome ETF (PBE) last traded at $98.72, with a market cap of 0 and a price-to-earnings ratio of 0.00.

Today the fund has traded between $97.57 and $98.72. The current price is 1.2% above the day's low and 0.0% below its high.

Volume so far is 7.73K shares, below the average of 13.39K shares a day.

Over the past year Invesco Biotechnology & Genome ETF has ranged from $72.27 to $99.99, and now sits 95% of the way up that range.

PBE news

  • Chandrima Sanyal

    Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.